Monoclonal antibodies with neuroblastoma specificity: A flow cytometric analysis of cross-reactivity with CD34+ hematopoietic stem cells

Journal of Hematotherapy and Stem Cell Research

Volumn 9, Issue 6, 2000, Pages 867-875

  Ifversen, M ^a   Christensen, L D ^a   Rechnitzer, C ^a   Heilmann, C ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; IMMUNOGLOBULIN ANTIBODY; MONOCLONAL ANTIBODY; NEUROBLASTOMA SPECIFIC MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CELL SEPARATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKAPHERESIS; NEUROBLASTOMA; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; CROSS REACTIONS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; MICE; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0034486331     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581600750062309     Document Type: Article

References (29)

1. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup?
2. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent Children's Cancer Group results
3. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: A Childrens Cancer Group pilot study
4. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells
5. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres
6. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads
7. Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads
8. Evaluation of a modified immunomagnetic procedure for the purging of neuroblastoma cells from bone marrow
9. Pediatric experience with autologous peripheral blood progenitor cell transplantation: Influence of CD34+ cell dose in engraftment kinetics
10. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy
11. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma
12. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies
13. Immunological detection of neuro-blastoma cells in bone marrow harvested for autologous transplantation
14. Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry
15. Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation
16. Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA
17. Expression of CD34 and other haematopoietic antigens on neuroblastoma cells: Consequences for autologous bone marrow and peripheral blood stem cell transplantation
18. Positive selection and transplantation of peripheral CD34+ progenitor cells: Feasibility and purging efficacy in pediatric patients with neuroblastoma
19. A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies
20. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells
21. Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders
22. Human Thy-1: Expression on the cell surface of neuronal and glial cells
23. Expression of Thy-1 on human hematopoietic progenitor cells
24. Extensive phenotypic analysis of CD34 subsets in successive collections of mobilized peripheral blood progenitors
25. Immunomagnetic depletion of malignant cells from autologous bone marrow graft: From experimental models to clinical trials
26. Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: Implications for purification of CD34-positive progenitor cells
27. CD34+ positive haemopoietic cells: Biology and clinical applications
28. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma
29. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast cancer patients by negative immunomagnetic separation